Bristol-Myers Squibb, a global biopharmaceutical company, has appointed Charles Bancroft as acting chief financial officer (CFO) and announced that Jean-Marc Huet, executive vice president and CFO, will leave the company at the end of 2009.
Bancroft was most recently vice president, finance for Bristol-Myers Squibb’s global biopharmaceutical business. In his new role, Bancroft will continue to report to Lamberto Andreotti, president and chief operating officer (COO).
Bancroft joined Bristol-Myers in 1984 and has since held positions of increasing responsibility within the finance organisation, including international assignments, senior leadership positions in the global pharmaceutical business and also with ConvaTec. He received his BS in Accounting from Drexel University, his MBA in Finance from Temple University, and is a certified public accountant (CPA).
The annual BNP Paribas Cash Management University kicked off on Thursday morning with treasury professionals congregating in Paris from across Europe.
APIs may be a solution to MT940 challenges, says Karen Fagan, treasury operation manager, for British television company, ITV.
Kicking off the first day of the Singapore Fintech Festival, issues with cryptocurrencies were addressed by MIT media labs director, Joi Ito, and panels of technology leaders discussed how they’re using data analytics.
Sibos 2017 day two highlights: Brexit and banking, and why ‘data is the new oil’ in financial services
How nation first politics can impact global financial organisations It’s clear that data and regulation are the two key topics that are ... read more